Current studies on PAQR3 have found that this molecule acts as a tumor suppressor in NSCLC, BRCA, PA (pulmonary adenocarcinoma) and other tumors to inhibit tumor proliferation, promote tumor cell apoptosis and sensitivity to targeted drugs, and is related to the clinical stage and prognosis of the disease3,7–9. Here, PAQR3 is linked to neoplasm.